PL2582359T3 - Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania - Google Patents

Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania

Info

Publication number
PL2582359T3
PL2582359T3 PL11727518T PL11727518T PL2582359T3 PL 2582359 T3 PL2582359 T3 PL 2582359T3 PL 11727518 T PL11727518 T PL 11727518T PL 11727518 T PL11727518 T PL 11727518T PL 2582359 T3 PL2582359 T3 PL 2582359T3
Authority
PL
Poland
Prior art keywords
granulates
powders
obtaining
active ingredients
oral administration
Prior art date
Application number
PL11727518T
Other languages
English (en)
Inventor
Walter Bertin
Andrea Fratter
Original Assignee
Labomar S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labomar S.R.L. filed Critical Labomar S.R.L.
Publication of PL2582359T3 publication Critical patent/PL2582359T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
    • A23P10/47—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added using additives, e.g. emulsifiers, wetting agents or dust-binding agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11727518T 2010-06-21 2011-05-12 Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania PL2582359T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A001119A IT1400695B1 (it) 2010-06-21 2010-06-21 Composizioni farmaceutiche e/o nutraceutiche contenenti principi attivi insolubili in acqua e procedimento per ottenerle.
PCT/IB2011/001017 WO2011161501A2 (en) 2010-06-21 2011-05-12 Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them
EP11727518.0A EP2582359B1 (en) 2010-06-21 2011-05-12 Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them

Publications (1)

Publication Number Publication Date
PL2582359T3 true PL2582359T3 (pl) 2018-02-28

Family

ID=43536597

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11727518T PL2582359T3 (pl) 2010-06-21 2011-05-12 Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania

Country Status (5)

Country Link
EP (1) EP2582359B1 (pl)
ES (1) ES2643493T3 (pl)
IT (1) IT1400695B1 (pl)
PL (1) PL2582359T3 (pl)
WO (1) WO2011161501A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2494477A (en) * 2011-09-12 2013-03-13 Works With Water Nutraceuticals Ltd A nutraceutical supplement
ITMI20120847A1 (it) 2012-05-16 2013-11-17 Labomar S R L Formulazione per sostanze a bassa biodisponibilità.
ES2666836T3 (es) 2014-06-04 2018-05-08 Alfasigma S.P.A. Formulaciones homogéneas que comprenden ácidos grasos poliinsaturados omega-3 (n-3 PUFA) y resveratrol para administración oral
EP2952180B1 (en) 2014-06-04 2017-01-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)
ITUA20161285A1 (it) * 2016-02-19 2017-08-19 Farm Procemsa S P A Composizione e metodo per l'ottenimento di emulsioni e dispersioni micellari stabili di grado alimentare tramite l'impiego di acidi grassi mono e polinsaturi.
ITUB20161247A1 (it) * 2016-03-02 2017-09-02 Labomar S R L Compressa orodispersibile contenente un principio attivo liposolubile
ITUA20164228A1 (it) * 2016-06-09 2017-12-09 Labomar S R L Formulazione a matrice grassa auto-emulsionante e gastro-resistente e relativo metodo di preparazione
IT202100026924A1 (it) * 2021-10-20 2023-04-20 Geofarma S R L Composizione a base di Palmitoiletanolamide in forma di polveri ad elevata bioaccessibilità enterica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
WO2006085217A2 (en) * 2005-02-08 2006-08-17 Pfizer Products Inc. Solid adsorbates of hydrophobic drugs

Also Published As

Publication number Publication date
WO2011161501A3 (en) 2012-04-19
EP2582359B1 (en) 2017-07-12
IT1400695B1 (it) 2013-06-28
ES2643493T3 (es) 2017-11-23
EP2582359A2 (en) 2013-04-24
ITMI20101119A1 (it) 2011-12-22
WO2011161501A2 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
IL255113A0 (en) Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
PL2582359T3 (pl) Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania
EP2536295A4 (en) FOOD SUPPLEMENT COMPOSITIONS FOR RUMINANTS AND METHODS OF MAKING AND USING SAME
HK1175947A1 (en) Pharmaceutical compositions and methods of making same
IL226377A0 (en) Preparations of isoflavone nanoparticles and methods for their preparation and use
IL222969A0 (en) Sweetener compositions and methods of preparing the same
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
IL218490A (en) Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations
GB2478849A8 (en) Improved pharmaceutical compositions and methods of delivery
HK1166258A1 (en) A method for the preparation of high temperature stable oxygen-carrier- containing pharmaceutical composition and the use thereof
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
EP2635260A4 (en) COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS
HK1171696A1 (en) Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof 5-ht4
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
EP2560614A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION
EP2717899A4 (en) PHARMACEUTICAL COMPOSITIONS BASED ON SHK AND METHODS OF MAKING AND USING THE SAME
IL217614A (en) Indolysin and 5-Azo-Indolysin Ring Carboxyamides, Their Converted History and Pharmaceuticals Containing Them
EP2618844A4 (en) ORAL FORMABLE COMPOSITION AND METHOD FOR THEIR PRODUCTION AND USE
PL2474306T3 (pl) Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza
IL224191A (en) Compositions of vitamin d and cmc epi-14 analogues
EP2599485A4 (en) COMPOSITION CONTAINING FAT AND ORAL FORMULATION CONTAINING THE SAME
WO2012007758A3 (en) Pharmaceutical formulations
EP2381929A4 (en) PHARMACEUTICAL COMPOSITION OF A LYOPHILIZED FORMULA AND METHOD FOR THE PRODUCTION THEREOF
IL220839B (en) History of 3-phenylamino-9-azabicyclo[1.3.3]nonane and pharmaceutical preparations containing them